As the clinical research landscape continues to evolve, so does our collective responsibility to shape its future with rigor, innovation, and inclusivity. JSCDM’s Fall 2025 Issue reflects the dynamic pulse of our field—where data standards, digital tools, and decentralized models converge to redefine how trials are designed, conducted, and scaled.

From the pioneering efforts at Tohoku University Hospital to standardize academic trial data using CDISC, to the development of external data quality pipelines with REDCap, our contributors demonstrate how technology is not just a tool but a catalyst for transformation. The implementation of fully decentralized trial designs in psycho-oncology and the real-time transition to eSource platforms underscore the urgency and promise of modernizing clinical workflows.

We also spotlight the regulatory lens with a comprehensive assessment of FDA’s global GCP inspections, reminding us that innovation must be matched with accountability. And in a forward-looking perspective from the SCDM Executive Committee, we explore how artificial intelligence, hybrid trial designs, and data-driven strategies will shape the next generation of clinical research.

Together, these articles offer a blueprint for collaboration across academia, industry, and regulatory bodies. A blueprint for scalable, ethical, and patient-centric trials. And most importantly, they offer a blueprint for a future where clinical data plays a central role in advancing scientific progress.

We hope you enjoy this issue and find inspiration in the ideas and experiences shared. Thank you for being part of the SCDM community—and for helping shape the future of clinical data management.

Warm regards,

Claudine Moore, MM, CCDM©

JSCDM Chief Editor